|
Status |
Public on Sep 13, 2019 |
Title |
Gene expression profiling of CHIR99021-induced skeletal myogenesis in human pluripotent stem cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Human pluripotent stem cell- (hPSC)-derived skeletal muscle progenitors (SMP)—defined as PAX7-expressing cells with myogenic potential—can provide an abundant source of donor material for muscle stem cell therapy owing to the near-infinite replication potential of PSCs. As in vitro myogenesis is decoupled from in vivo timing and the 3D-embryo structure, it remains difficult to definitively characterize what stage or type of muscle is modeled in culture. Here, gene expression profiling is analyzed in hPSCs over a 50 day skeletal myogenesis protocol and compared to gene expression datasets of other hPSC-derived skeletal muscle and adult murine satellite cells. Furthermore, day 2 cultures differentiated with high or lower concentrations of CHIR99021 were contrasted. Expression profiling of the 50 day time course identified successively expressed gene subsets involved in mesoderm/paraxial mesoderm induction, somitogenesis, and skeletal muscle commitment/formation which could be regulative by a putative cascade of transcription factors. Initiating differentiation with higher CHIR99021 concentrations resulted in significantly higher expression of MSGN1 and TGFB-superfamily genes, notably NODAL, resulting in enhanced paraxial mesoderm and reduced ectoderm/neuronal gene expression. Comparison to adult satellite cells revealed that genes expressed in day 50 cultures correlated better with those expressed by quiescent or early activated satellite cells, which have a greater therapeutic potential than late activated satellite cells. Day 50 cultures were similar to other hPSC-derived skeletal muscle and both expressed known and novel SMP surface proteins.
|
|
|
Overall design |
24 samples were analyzed, reflecting 8 experimental conditions with 3 biological replicates each. Day 0 samples were used as a reference in downstream analysis to establish altered levels of gene expression at the later stages of differentiation.
|
|
|
Contributor(s) |
Shelton M, Blais A |
Citation(s) |
31560727 |
|
Submission date |
May 13, 2019 |
Last update date |
May 10, 2023 |
Contact name |
Alexandre Blais |
E-mail(s) |
[email protected]
|
Organization name |
University of Ottawa
|
Street address |
451 Smyth Road
|
City |
Ottawa |
State/province |
ON |
ZIP/Postal code |
K1H 8M5 |
Country |
Canada |
|
|
Platforms (1) |
GPL20844 |
Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Feature Number Version] |
|
Samples (24)
|
|
Relations |
BioProject |
PRJNA542692 |